Investing.com - Redhill ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Redhill ADR announced earnings per share of $-0.05 on revenue of $20.94M. Analysts polled by Investing.com anticipated EPS of $-0.27 on revenue of $25.36M.
Redhill ADR shares are up 35.42% from the beginning of the year and are trading at $8.20 , down-from-52-week-high.They are outperforming the Nasdaq which is up 31.36% from the start of the year.
Redhill ADR shares lost 0.24% in pre-market trade following the report.
Redhill ADR follows other major Healthcare sector earnings this month
Redhill ADR's report follows an earnings beat by Pfizer on Tuesday, October 27, 2020, who reported EPS of $0.72 on revenue of $12.13B, compared to forecasts EPS of $0.71 on revenue of $12.31B.
Merck&Co had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of $1.74 on revenue of $12.55B, compared to forecast for EPS of $1.44 on revenue of $12.21B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar